Factors Predictive of Obliteration After Arteriovenous Malformation Radiosurgery
Chris Herbert(BC Cancer Agency), Michel Martin(BC Cancer Agency), K. Luchka(BC Cancer Agency), Ermias Gete(BC Cancer Agency), A. Lee(Royal Columbian Hospital), R. Lee(BC Cancer Agency), Charles S. Haw(University of British Columbia), Brian Toyota(University of British Columbia), Michael McKenzie(Provincial Health Services Authority), Gary Redekop(Western University), F. Hsu(Abbotsford Veterinary Clinic), B.S. Gill, Vitali Moiseenko(BC Cancer Agency)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
November 1, 2011
Cited by 8
Related Papers
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage
|Journal of neurosurgery|1998|416
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2017|319